Neurophysiological assessment of painful neuropathies.

Expert Rev Neurother

Department of Neurology, Electromyography, Neuropathic Pain and Motor Control Unit, Hospital Clínic, Institut d'Investigació August Pi i Sunyer, Universidad de Barcelona, Villarroel, 170, Barcelona 08036, Spain.

Published: November 2012

Nociceptive inputs reach the CNS by means of small myelinated and unmyelinated fibers. Owing to this, conventional nerve conduction studies and electromyography are less likely to demonstrate abnormalities in neuropathies affecting nociceptive fibers than in those involving large myelinated fibers. Therefore, to characterize painful neuropathies, clinicians evaluate the features of the lesion that cause pain rather than the feeling of pain itself. Clinical neurophysiological assessment of painful neuropathies still relies on conventional nerve conduction studies but slightly more sophisticated techniques bring more specific information. These are the nociceptive-evoked potentials, microneurography or autonomic nervous system functional tests. Neurophysiological techniques can also add information to quantitative sensory testing by recording autonomic responses such as the sudomotor skin response or the voluntary reaction. Functional magnetic resonance should also be considered as a neurophysiological technique, which allows for mapping the areas of the brain involved in nociceptive sensation and pain control.

Download full-text PDF

Source
http://dx.doi.org/10.1586/ern.12.93DOI Listing

Publication Analysis

Top Keywords

painful neuropathies
12
neurophysiological assessment
8
assessment painful
8
neuropathies nociceptive
8
conventional nerve
8
nerve conduction
8
conduction studies
8
neurophysiological
4
neuropathies
4
nociceptive inputs
4

Similar Publications

A 78-years-old man was treated for asthma and pansinusitis for >5 years, and mepolizumab was initiated two years previously. Two months after the cessation of mepolizumab treatment, the asthma symptoms worsened and acute progressive muscle weakness and sensory disturbance developed. On day 8 after the onset of weakness and hypoesthesia, the patient presented with complete flaccid tetraplegia and diffuse hypoesthesia of all extremities, without paresthesia or pain, and was admitted to our hospital.

View Article and Find Full Text PDF

Postpartum pyogenic sacroiliitis masquerading as sciatic neuropathy.

BMJ Case Rep

January 2025

Department of Orthopedics, SDM College of Medical Sciences and Hospital, Shri Dharmasthala Manjunatheshwara University, Dharwad, Karnataka, India.

Low back pain is common in women, especially during pregnancy and puerperium. Septic sacroiliitis, a rare cause of back pain in the postpartum period can mimic other common causes of low back pain like muscle strain, urinary tract infection, pelvic inflammatory disease, endometritis and intervertebral disc prolapse. The proximity of the sacroiliac joint to the sacral nerve plexus results in septic sacroiliitis frequently presenting with symptoms mimicking intervertebral disc prolapse.

View Article and Find Full Text PDF

Introduction: Although the prevalence of chemotherapy-induced peripheral neuropathy (CIPN) has been reported, the proportion of patients with CIPN who report chronic painful neuropathy remains poorly understood, despite its significant impact on patients' quality of life and treatment outcomes.

Methods: A systematic review and meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The primary outcome was the pooled prevalence of chronic (≥3 months) painful CIPN among patients diagnosed with CIPN.

View Article and Find Full Text PDF

The pathogenesis of painful diabetic neuropathy (PDN) is complicated and remains not fully understood. A disintegrin and metalloprotease 17 (ADAM17) is an enzyme that is responsible for the degradation of membrane proteins. ADAM17 is known to be activated under diabetes, but its involvement in PDN is ill defined.

View Article and Find Full Text PDF

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious side effect of anticancer agents with limited effective preventive or therapeutic interventions. Although fenofibrate, a peroxisome proliferator-activated receptor-alpha (PPARα) agonist, has demonstrated neuroprotective and analgesic properties, its clinical utility is hindered by low receptor affinity, poor subtype selectivity, and suboptimal bioavailability. A190, a highly selective and potent nonfibrate PPARα agonist, offers a promising alternative but is limited by poor aqueous solubility, resulting in reduced oral bioavailability and therapeutic efficacy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!